ASTRANA HEALTH INC (ASTH) Stock Overview
NASDAQ:ASTH - US03763A2078 - Common Stock
ASTH Key Statistics, Chart & Performance
The current stock price of ASTH is 31.96 USD. In the past month the price increased by 48.17%. In the past year, price decreased by -33.12%.
ASTH Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 11.54 | 92.78B | ||
| CI | THE CIGNA GROUP | 10.71 | 80.31B | ||
| LH | LABCORP HOLDINGS INC | 18.36 | 23.10B | ||
| DGX | QUEST DIAGNOSTICS INC | 19.2 | 20.31B | ||
| FMS | FRESENIUS MEDICAL CARE-ADR | 12.6 | 15.08B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 110.31 | 14.46B | ||
| DVA | DAVITA INC | 14.22 | 9.85B | ||
| HIMS | HIMS & HERS HEALTH INC | 52.94 | 9.57B | ||
| GH | GUARDANT HEALTH INC | N/A | 8.41B | ||
| CHE | CHEMED CORP | 20.47 | 6.67B | ||
| RDNT | RADNET INC | 199.33 | 5.52B | ||
| OPCH | OPTION CARE HEALTH INC | 21.24 | 4.65B |
Related stock screener links
About ASTH
Company Profile
Astrana Health, Inc. is a physician-centric, technology-powered, risk-bearing healthcare management company. The company is headquartered in Alhambra, California and currently employs 1,900 full-time employees. The firm provides care coordination services to each major constituent of the healthcare delivery system, including patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The firm's segments include Care Partners, Care Delivery, and Care Enablement. Its Care Partners segment is focused on building and managing provider networks by partnering with, empowering, and investing in provider partners aligned on a shared vision for coordinated care delivery. Its Care Delivery organization includes primary care, multi-specialty care, and ancillary care services. Its Care Enablement segment represents a comprehensive platform that integrates clinical, operational, financial, and administrative information. The company supports more than 20,000 providers.
Company Info
ASTRANA HEALTH INC
1668 S. Garfield Avenue, 2Nd Floor
Alhambra CALIFORNIA US
Employees: 1900
Phone: 16262820288
ASTRANA HEALTH INC / ASTH FAQ
What is the stock price of ASTRANA HEALTH INC today?
The current stock price of ASTH is 31.96 USD. The price increased by 2.01% in the last trading session.
What is the ticker symbol for ASTRANA HEALTH INC stock?
The exchange symbol of ASTRANA HEALTH INC is ASTH and it is listed on the Nasdaq exchange.
On which exchange is ASTH stock listed?
ASTH stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for ASTRANA HEALTH INC stock?
17 analysts have analysed ASTH and the average price target is 44.77 USD. This implies a price increase of 40.07% is expected in the next year compared to the current price of 31.96. Check the ASTRANA HEALTH INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is ASTRANA HEALTH INC worth?
ASTRANA HEALTH INC (ASTH) has a market capitalization of 1.60B USD. This makes ASTH a Small Cap stock.
How many employees does ASTRANA HEALTH INC have?
ASTRANA HEALTH INC (ASTH) currently has 1900 employees.
What are the support and resistance levels for ASTRANA HEALTH INC (ASTH) stock?
ASTRANA HEALTH INC (ASTH) has a support level at 29.11 and a resistance level at 31.97. Check the full technical report for a detailed analysis of ASTH support and resistance levels.
Is ASTRANA HEALTH INC (ASTH) expected to grow?
The Revenue of ASTRANA HEALTH INC (ASTH) is expected to grow by 61.45% in the next year. Check the estimates tab for more information on the ASTH EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy ASTRANA HEALTH INC (ASTH) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of ASTH, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of ASTH, evaluating the profitability, health, valuation and growth aspects
- ASTRANA HEALTH INC (ASTH) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- ASTRANA HEALTH INC (ASTH) Sales and EPS estimates to see what analysts future expectations are.
- ASTRANA HEALTH INC (ASTH) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- ASTRANA HEALTH INC (ASTH) Insider and Institutional Ownership to learn about the owners and their transactions.
- ASTRANA HEALTH INC (ASTH) Stock Chart to make your own analysis
- ASTRANA HEALTH INC (ASTH) Latest news and press-releases to stay up to date.
Does ASTRANA HEALTH INC (ASTH) stock pay dividends?
ASTH does not pay a dividend.
When does ASTRANA HEALTH INC (ASTH) report earnings?
ASTRANA HEALTH INC (ASTH) will report earnings on 2025-11-05, after the market close.
What is the Price/Earnings (PE) ratio of ASTRANA HEALTH INC (ASTH)?
The PE ratio for ASTRANA HEALTH INC (ASTH) is 62.67. This is based on the reported non-GAAP earnings per share of 0.51 and the current share price of 31.96 USD. Check the full fundamental report for a full analysis of the valuation metrics for ASTH.
What is the Short Interest ratio of ASTRANA HEALTH INC (ASTH) stock?
The outstanding short interest for ASTRANA HEALTH INC (ASTH) is 4.13% of its float. Check the ownership tab for more information on the ASTH short interest.
ASTH Technical Analysis
ChartMill assigns a technical rating of 7 / 10 to ASTH. When comparing the yearly performance of all stocks, ASTH is a bad performer in the overall market: 73.39% of all stocks are doing better.
ASTH Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to ASTH. The financial health of ASTH is average, but there are quite some concerns on its profitability.
ASTH Financial Highlights
Over the last trailing twelve months ASTH reported a non-GAAP Earnings per Share(EPS) of 0.51. The EPS decreased by -64.58% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 1.04% | ||
| ROA | 1.75% | ||
| ROE | 3.3% | ||
| Debt/Equity | 0.52 |
ASTH Forecast & Estimates
17 analysts have analysed ASTH and the average price target is 44.77 USD. This implies a price increase of 40.07% is expected in the next year compared to the current price of 31.96.
For the next year, analysts expect an EPS growth of 47.59% and a revenue growth 61.45% for ASTH